MEPIVASTESIN

This brand name is authorized in Ecuador, Hong Kong, Lithuania, Poland, Romania, Singapore

Active ingredients

The drug MEPIVASTESIN contains one active pharmaceutical ingredient (API):

1 Mepivacaine
UNII 4VFX2L7EM5 - MEPIVACAINE HYDROCHLORIDE

Mepivacaine is an amide local anaesthetic. Mepivacaine has a rapid onset, a high potency of anaesthesia and a low toxicity.

Read about Mepivacaine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N01BB03 Mepivacaine N Nervous system → N01 Anesthetics → N01B Anesthetics, local → N01BB Amides
Discover more medicines within N01BB03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 26.955-03-06
Country: HK Department of Health Drug Office Identifier(s): 25907
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1011839
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100042751
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W58075001
Country: SG Health Sciences Authority Identifier(s): 06179P

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.